A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)
Clinical trial NCT05755906 · COMPLETED
Trial details
- NCT number
- NCT05755906
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-27
- Primary completion
- 2024-11-19
- Enrollment
- 374
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.